Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions
Mohammad Alzrigat et al.
ONCOTARGET (2017)
In vitro anticancer properties of selected Eucalyptus species
Deep Jyoti Bhuyan et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2017)
CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion
Xin Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer
Zhixin Ling et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression
Kazuhiro Yoshida et al.
CARCINOGENESIS (2017)
Diosgenin-induced autophagy and apoptosis in a human prostate cancer cell line
Chao Nie et al.
MOLECULAR MEDICINE REPORTS (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells
Xiuxia Zhou et al.
ONCOTARGET (2016)
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
Elena Gabriela Chiorean et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Advances in the pharmacological activities and mechanisms of diosgenin
Chen Yan et al.
CHINESE JOURNAL OF NATURAL MEDICINES (2015)
An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
Kyle D. Konze et al.
ACS CHEMICAL BIOLOGY (2013)
Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980
C. Bosetti et al.
ANNALS OF ONCOLOGY (2013)
Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression
P. Liu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
BRCA1 is a negative modulator of the PRC2 complex
Lan Wang et al.
EMBO JOURNAL (2013)
Therapeutic targets associated to E-cadherin dysfunction in gastric cancer
Patricia Carneiro et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Current concepts and novel targets in advanced pancreatic cancer
Patrick Michl et al.
GUT (2013)
Transcriptional regulation by Polycomb group proteins
Luciano Di Croce et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter
Lilian E. van Vlerken et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Pancreatic cancer: Overview of descriptive epidemiology
Cristina Bosetti et al.
MOLECULAR CARCINOGENESIS (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101
Aamer M. Qazi et al.
SURGERY (2012)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells
Feng Li et al.
CANCER LETTERS (2010)
Polycomb group protein-mediated repression of transcription
Lluis Morey et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
E-Cadherin Regulates Metastasis of Pancreatic Cancer In Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex
Johannes von Burstin et al.
GASTROENTEROLOGY (2009)
Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells
Sowmyalakshmi Srinivasan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Mechanisms of Polycomb gene silencing: knowns and unknowns
Jeffrey A. Simon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q. Cao et al.
ONCOGENE (2008)
Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, IκB kinase activation and NF-κB-regulated gene expression
S Shishodia et al.
ONCOGENE (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice
SWM Bruggeman et al.
GENES & DEVELOPMENT (2005)
Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer
H Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Trigonella foenum graecum (Fenugreek) seed extract as an antineoplastic agent
P Sur et al.
PHYTOTHERAPY RESEARCH (2001)
Share Paper
